[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FI932759A0 - Anvaendningen av IL-4 foer oekning av pao vacciners immunogener verkande immunreaktioner - Google Patents

Anvaendningen av IL-4 foer oekning av pao vacciners immunogener verkande immunreaktioner

Info

Publication number
FI932759A0
FI932759A0 FI932759A FI932759A FI932759A0 FI 932759 A0 FI932759 A0 FI 932759A0 FI 932759 A FI932759 A FI 932759A FI 932759 A FI932759 A FI 932759A FI 932759 A0 FI932759 A0 FI 932759A0
Authority
FI
Finland
Prior art keywords
immunoreaction
vaccinia
immunogenic
enhancement
generic
Prior art date
Application number
FI932759A
Other languages
English (en)
Other versions
FI932759A (fi
Inventor
Edward J Rozhon
John F O'connell
Stuart A Cox
Michael D Hayre
Jerome Schwartz
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of FI932759A publication Critical patent/FI932759A/fi
Publication of FI932759A0 publication Critical patent/FI932759A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2026—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A61K2039/55527—Interleukins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Peptides Or Proteins (AREA)
FI932759A 1990-12-19 1993-06-16 Anvaendningen av IL-4 foer oekning av pao vacciners immunogener verkande immunreaktioner FI932759A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62980090A 1990-12-19 1990-12-19
PCT/US1991/009167 WO1992011030A1 (en) 1990-12-19 1991-12-17 Use of il-4 to enhance immune response to immunogens in vaccines

Publications (2)

Publication Number Publication Date
FI932759A FI932759A (fi) 1993-06-16
FI932759A0 true FI932759A0 (fi) 1993-06-16

Family

ID=24524543

Family Applications (1)

Application Number Title Priority Date Filing Date
FI932759A FI932759A0 (fi) 1990-12-19 1993-06-16 Anvaendningen av IL-4 foer oekning av pao vacciners immunogener verkande immunreaktioner

Country Status (20)

Country Link
EP (1) EP0563254B1 (fi)
JP (1) JPH06503830A (fi)
CN (1) CN1063227A (fi)
AT (1) ATE129900T1 (fi)
AU (1) AU9161591A (fi)
CA (1) CA2098726A1 (fi)
CZ (1) CZ119993A3 (fi)
DE (1) DE69114519T2 (fi)
DK (1) DK0563254T3 (fi)
ES (1) ES2079851T3 (fi)
FI (1) FI932759A0 (fi)
GR (1) GR3018820T3 (fi)
HU (1) HUT68529A (fi)
IE (1) IE70453B1 (fi)
IL (1) IL100402A0 (fi)
OA (1) OA09863A (fi)
PT (1) PT99838A (fi)
SK (1) SK59393A3 (fi)
WO (1) WO1992011030A1 (fi)
ZA (1) ZA919907B (fi)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5268454A (en) 1991-02-08 1993-12-07 La Jolla Pharmaceutical Company Composition for inducing humoral anergy to an immunogen comprising a t cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic carrier
US7449186B1 (en) * 1990-08-02 2008-11-11 Fred Hutchinson Cancer Research Center Methods of blocking the interaction between stromal cells and hemopoietic cells with anti-VCAM-1 antibodies
US5827670A (en) * 1990-08-02 1998-10-27 Fred Hutchinson Cancer Research Center Methods of isolating and detecting bone marrow stromal cells with VCAM-1-specific antibodies
US5206345A (en) * 1990-08-02 1993-04-27 Fred Hutchinson Cancer Research Center Il-4 and tnf induce mab 6g10-recognized expression on bone marrow stromal cells
AU688736B2 (en) * 1992-08-10 1998-03-19 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Interleukin-4 stimulated T lymphocyte cell death
WO1994028871A1 (en) * 1993-06-07 1994-12-22 Endocon, Inc. Implant stimulated cellular immunity
AU695883B2 (en) * 1994-04-08 1998-08-27 Brigham And Women's Hospital Treatment of autoimmune disease using oral tolerization and/or Th2-enhancing cytokines
US6660258B1 (en) 1997-05-09 2003-12-09 Pharma Pacific Pty Ltd Oromucosal cytokine compositions and uses thereof
FR2769505B1 (fr) * 1997-10-10 2000-06-30 Michael Gerard Tovey Compositions de cytokines a administrer a la muqueuse buccale, et leurs utilisations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL80678A (en) * 1985-11-19 1999-05-09 Schering Biotech Corp Human interleukin-4
ZA875681B (en) * 1986-08-01 1988-04-27 Commw Scient Ind Res Org Recombinant vaccine
JP3485184B2 (ja) * 1989-07-14 2004-01-13 アメリカン サイアナミド カンパニー インターロイキン含有安定ワクチン組成物
DE69116552T2 (de) * 1990-03-21 1996-05-30 Schering Corp Verwendung von il-4 zur verstärkung der immunantwort auf infektiöse antigen-herausforderungen

Also Published As

Publication number Publication date
SK59393A3 (en) 1994-03-09
FI932759A (fi) 1993-06-16
DE69114519D1 (de) 1995-12-14
IL100402A0 (en) 1992-09-06
DK0563254T3 (da) 1996-02-12
CZ119993A3 (en) 1994-02-16
GR3018820T3 (en) 1996-04-30
EP0563254B1 (en) 1995-11-08
IE914436A1 (en) 1992-07-01
HUT68529A (en) 1995-06-28
DE69114519T2 (de) 1996-04-04
EP0563254A1 (en) 1993-10-06
ATE129900T1 (de) 1995-11-15
AU9161591A (en) 1992-07-22
CN1063227A (zh) 1992-08-05
IE70453B1 (en) 1996-11-27
ES2079851T3 (es) 1996-01-16
PT99838A (pt) 1992-12-31
CA2098726A1 (en) 1992-06-20
WO1992011030A1 (en) 1992-07-09
JPH06503830A (ja) 1994-04-28
OA09863A (en) 1994-08-15
ZA919907B (en) 1992-08-26
HU9301797D0 (en) 1993-10-28

Similar Documents

Publication Publication Date Title
MX9304089A (es) Uso de gm-csf como una vacuna adyuvante.
ES2176232T3 (es) Vacuna adecuada para ser utilizada en la prevencion y tratamiento de la infeccion por helicobacter.
CA2033640A1 (en) Vaccines against cancer and infectious diseases
ES2149776T3 (es) Modulacion, inducida por un morfogeno, de la respuesta inflamatoria.
UA40597C2 (uk) Вакцинна композиція,спосіб лікування ссавців, що страждають або сприйнятливі до інфекції, спосіб лікування ссавців, що страждають на рак, спосіб одержання вакцинної композиції, композиція ад'ювантів
CA2169764A1 (en) Dampening of an immunodominant epitope of an antigen for use in plant, animal and human vaccines and immunotherapies
ES2196024T3 (es) Vacunas conjugadas de gangliosido-klh con qs-21.
ES2156199T3 (es) Polipeptido inductor de la produccion de interferon-gamma, anticuerpos monoclonales y composicion para el tratamiento o la prevencion de enfermedades sensibles al interferon-gamma.
NZ218825A (en) Use of low dosages of interferon as adjuvants for vaccines
FI932759A0 (fi) Anvaendningen av IL-4 foer oekning av pao vacciners immunogener verkande immunreaktioner
ATE261314T1 (de) P53 impfstoff
NZ312502A (en) Clostridium difficile toxins as mucosal adjuvants
IL97600A0 (en) Use of il-4 to enhance immune response to infectious antigenic challenges
EP0414816A4 (en) Induction of tolerance to a foreign antigen
EP0293333A3 (en) A synthetic nonapeptide of use as an adjuvant
RU93043610A (ru) Фармацевтическая композиция для усиления первичной иммуно-реакции у млекопитающих, способ усиления первичной иммуно-реакции и применение интерлейкина-4 для усиления первичной иммуно-реакции у млекопитающих, набор лекарственных средств
ATE145335T1 (de) Kreuzreaktive immunisierung gegen influenza
SE8400934D0 (sv) Forfarande for framstellning av lyofiliserade, adsorberade, polyvalenta vacciner

Legal Events

Date Code Title Description
FD Application lapsed